NCT01578772View on ClinicalTrials.gov

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Endothelial Dysfunction
Interventions
DRUG

Telmisartan

80mg tablets po daily for 6 weeks

Trial Locations (1)

90035

UCLA CARE Center, Los Angeles

All Listed Sponsors
collaborator

The Campbell Foundation

OTHER

lead

University of California, Los Angeles

OTHER

NCT01578772 - A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease | Biotech Hunter | Biotech Hunter